Immunotherapy

Thursday, January 24, 2019 - 8:00am
“For me, it’s kind of a miracle. I have the second chance in life that I never thought I’d have.”
Wednesday, November 14, 2018 - 8:00am
Dr. Lee says hopes are high for the success of immunotherapies targeting multiple myeloma: “I think we’re seeing a major change in the way we take care of the disease.”
Monday, October 22, 2018 - 11:10am
What can be done when cancer is able to hide from your immune system or block the immune response, or if it just isn’t strong enough to kill all the cancer cells?
Friday, August 31, 2018 - 8:30am
Dr. Odunsi and his colleagues observed that the tumors of some patients were full of T cells that had managed to work their way inside the tumor. When there were many of these T cells, the patients tended to live longer.
Friday, August 24, 2018 - 9:00am

A combination of two immunotherapy drugs shows promise in treating patients with skin cancer that has spread to the brain, according to a study published this week the New England Journal of Medicine. Results of a clinical trial in 94 patients from 28 centers across the United States, in

Wednesday, August 1, 2018 - 11:36am
Not all patients respond to all types of immunotherapies. So how can doctors identify which treatments have the best chance of working in a specific patient? How can they quickly zero in on the best options on a list of immunotherapies that grows longer every day?
Thursday, May 17, 2018 - 8:00am

Roswell Park Comprehensive Cancer Center researchers have made another step toward personalizing cancer treatment while reducing the toxicity of certain cancer drugs using simple, noninvasive blood tests.

Wednesday, May 9, 2018 - 10:04am
We’re entering a hopeful new era with the development of immunotherapies, which use the power of your own immune system to fight cancer. Here's an introduction to one type, called CAR T-cell therapy.
Thursday, March 22, 2018 - 11:46am
Results from the CheckMate 214 clinical trial show that combined therapy with two immunotherapy drugs, nivolumab and ipilimumab, can be very effective in the treatment of renal cell carcinoma, the most common type of kidney cancer.
Thursday, March 8, 2018 - 9:00am
A new clinical trial open at Roswell Park Comprehensive Cancer Center is currently investigating whether beta blockers, which calm the body’s response to stress, can boost immunotherapy in patients with advanced melanoma.